Related Experiment Video
Updated: May 22, 2026

Quantitative Measurement of Intrathecally Synthesized Proteins in Mice
Published on: November 29, 2019
[Adhesion molecule in the cerebrospinal fluid in multiple sclerosis]
High levels of soluble PECAM in cerebrospinal fluid indicate new multiple sclerosis lesions and faster disability progression. This finding aids in understanding disease activity and patient outcomes.
Area of Science:
- Neuroimmunology
- Biomarkers in Neurology
Background:
- Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system.
- Adhesion molecules play a role in immune cell trafficking and neuroinflammation in MS.
Purpose of the Study:
- To investigate the association between adhesion molecule levels and disease activity in multiple sclerosis.
- To explore the predictive value of adhesion molecules for new lesion formation and disability progression.
Main Methods:
- Prospective study of 24 patients with multiple sclerosis over 3 years.
- Measurement of adhesion molecule levels, specifically sPECAM, in cerebrospinal fluid (CSF).
- Correlation of adhesion molecule levels with magnetic resonance imaging (MRI) findings (new foci) and clinical disability assessments.
Main Results:
- Elevated levels of soluble PECAM (sPECAM) in CSF were observed.
- High sPECAM levels significantly correlated with the appearance of new MRI-defined lesions.
- Increased sPECAM levels were associated with rapid disability progression in MS patients.
Conclusions:
- CSF sPECAM is a potential biomarker for active neuroinflammation in multiple sclerosis.
- sPECAM levels may predict disease progression and the development of new lesions.
- This research highlights the role of adhesion molecules in MS pathogenesis and clinical outcomes.
More Related Videos
11:10Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study
Published on: June 29, 2016
09:00Analysis of Lymphocyte Extravasation Using an In Vitro Model of the Human Blood-brain Barrier
Published on: April 5, 2017
Related Concept Videos
Cerebrospinal Fluid
CSF Production
CSF is produced mainly in the choroid plexus, a network of capillaries and ependymal cells located within the ventricular system of the brain.
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Cerebral Edema ll: Pathophysiology
The Blood-brain Barrier
Bacterial Meningitis II: Pathophysiology
Cerebral Edema l: Introduction